A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are slightly lower this morning. Futures for the Dow Jones Industrial Average dipped 15 points to 12,958.00 and S&P 500 index futures fell 2.60 points to 1,371.90. Nasdaq 100 futures dropped 3.50 points to 2,639.75.
A Peek Into Global Markets European markets were mixed today. The STOXX Europe 600 Index gained 0.15%, London's FTSE 100 Index moved down 0.12%, French CAC 40 index rose 0.13% and German DAX 30 index dropped 0.11%.
Asian markets ended higher, with Japan's Nikkei Stock Average rising 0.72%, China's Shanghai Composite gaining 1.43% and Australia's S&P/ASX 200 moving up 0.42%. Hong Kong's Hang Seng index rose 0.81% and India's Sensex gained 0.30%.
Broker Recommendation Analysts at Credit Suisse downgraded BlackRock Inc (NYSE: BLK) from “outperform” to “neutral.” The target price for BlackRock has been raised from $200 to $205.
BlackRock shares closed at $198.50 yesterday.
- Cameco (NYSE: CCJ) announced today that it has entered into an agreement with AREVA Resources Canada Inc. to purchase AREVA's 27.94% interest in the Millennium project for $150 million. To read the full news, click here.
- Sara Lee Corporation (NYSE: SLE) today announced that its wholly owned subsidiary, DE International Holdings has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the spin-off of Sara Lee's Coffee & Tea business and related transactions, which are described in the registration statement. To read the full news, click here.
- Acura Pharmaceuticals Inc (NASDAQ: ACUR) today announced independent laboratory tests demonstrated that NEXAFED, Acura's pseudoephedrine tablet product, disrupted the conversion of the pseudoephedrine in the product into methamphetamine. To read the full news, click here.
- Bona Film Group Limited (NASDAQ: BONA) announced today that its chief financial officer, Mr. Mason Xu, has tendered his resignation as CFO of the Company to become chief executive officer of a China-based, U.S.-dollar private equity fund. To read the full news, click here.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.